Satish Garg, MD

Recognitions

• ADA-Award, ADA (2008)
  
• RSSDI Oration, RSSDI (2007)
  
• PGIMER-Award, PGIMER (2006)
  

Research Interests

Same as above.

Publications

• Garg SK, Moser EG, Bode B, Klaff L, Hiatt WR, Beatson C, Snell-Bergeon JK. Effect of Sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: Investigator-initiated, double-blind, randomized, placebo-controlled trial. Endocr Pract. 2012 Nov 27;:1-30. [Epub ahead of print] PubMed PMID: 23186950
• Garg SK, DiDomenico D, Switzer S. Ways to reduce cardiovascular disease in diabetes. Diabetes Technol Ther. 2012 Jun;14 Suppl 1:S1-2. PubMed PMID: 22650219
• Switzer SM, Moser EG, Rockler BE, Garg SK. Intensive insulin therapy in patients with type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2012 Mar;41(1):89-104. PubMed PMID: 22575408
• Basu A, Alaupovic P, Wu M, Jenkins AJ, Yu Y, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, Lorentzen B, Clausen T, Garg SK, Menard MK, Hammad SM, Scardo JA, Stanley JR, Dashti A, Aston CE, Lyons TJ. Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. J Clin Endocrinol Metab. 2012 May;97(5):1752-62. PubMed PMID: 22438226
• Moser EG, Morris AA, Garg SK. Emerging diabetes therapies and technologies. Diabetes Res Clin Pract. 2012 Jul;97(1):16-26. PubMed PMID: 22381908
• Garg SK. Rising epidemic of diabetes and hypertension in Asia. Diabetes Technol Ther. 2012 Jan;14(1):1-2. PubMed PMID: 22070624
• Garg SK, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff D, Shin J, Welsh JB, Kaufman FR: Reduction of exercise induced hypoglycemia with automatic insulin suspension with Veo insulin pump system: The ASPIRE study. Diabetes Technology & Therapeutics, 14:205-209, 2012.
• Heller S, Buse J, Fisher M, Garg S, Marre M, Merker L, Renard E, Russell-Jones D, Ocampo Francisco AM, Pei H, Bode B, on behalf of the BEGIN Basal-Bolus Type 1 Trial Investigators.: Insulin degludec, an ultra-long-acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial. Lancet, 2012; 379: 1489-97.
• Yu Y, Hanssen KF, Kalyanaraman V, Chirindel A, Jenkins AJ, Nankervis AJ, Torjesen PA, Scholz H, Henriksen T, Lorentzen B, Garg SK, Menard MK, Hammad SM, Scardo JA, Stanley JR, Wu M, Basu A, Aston CE, and Lyons TJ: Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes preeclampsia in Type 1 diabetes. BJOG, 119(12):1512-20, 2012
• Garg S: Rationale for the use of insulin pumps and continuous glucose monitoring in adult patients. Endocrine Practice, Suppl 2, 18:10-12, 2012.
• Garg S: Making progress toward closed-loop insulin pump technology for patients with diabetes mellitus. Endocrine Practice, Suppl 2, 18:17-20, 2012.
• Garg SK, Hirsch IB. Self-monitoring of blood glucose-an overview. Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S3-S10. PubMed PMID: 24479597
• Garg SK, Shah VN. Newer therapies for diabetes management. Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S119-27. PubMed PMID: 24479593
• Garg SK. DTT Publishes the ATTD 2013 Yearbook. Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S1. PubMed PMID: 24479589
• Garg SK, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR. Hypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study. Diabetes Technol Ther. 2014 Jan 9. [Epub ahead of print] PubMed PMID: 24405492
• Garg SK, Michels AW, Shah VN. Use of non-insulin therapies for type 1 diabetes. Diabetes Technol Ther. 2013 Nov;15(11):901-8. PubMed PMID: 24131372
• Du M, Basu A, Fu D, Wu M, Centola M, Jenkins AJ, Hanssen KF, Garg SK, Hammad SM, Scardo JA, Aston CE, Lyons TJ: Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care, 36:2054-2061, 2013
• Garg SK, Maurer H, Reed K, Selagamsetty R. Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab. 2014 Feb;16(2):97-110. PubMed PMID: 23668396
• Garg SK, Moser EG, Bode B, Klaff L, Hiatt WR, Beatson C, Snell-Bergeon JK: Effect of Sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: Investigator-initiated, double-blind, randomized, placebo-controlled trial. Endocrine Practice, 19:1-10, 2013
• Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes. Diabetes Technol Ther. 2014 Feb;16(2):76-83. PubMed PMID: 24266497
• Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Buckingham B, Deeb L, Dolin R, Garg SK, Goland R, Hirsch I, Klonoff DC, Kruger DF, Matfin G, Mazze R, Parkin C, Peters A, Rodriguez, Southerland P, Strock ES, Tamborlane W, Wesley DM: Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in type 1 diabetes: the ambulatory glucose profile (AGP). Diabetes Technology & Therapeutics, 15:198-211, 2013.
• Garg S, Westerman A, Grey J, Reed K: Implementations on new SMBG Guidelines. US Endocrinology, 9(1): 26-29, 2013.
• Garg SK, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR. Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther. 2014 Mar;16(3):125-30. PubMed PMID: 24405492
• Garg SK, Hirsch IB. Self-monitoring of blood glucose--an overview. Diabetes Technol Ther. 2014 Feb;16 Suppl 1:S3-10. PubMed PMID: 24479597
• Bailey TS, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh JB, Lee SW. Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor. Diabetes Technol Ther. 2014 May;16(5):277-83. PubMed PMID: 24758729
• Garg SK, Buse JB, Skyler JS, Vaughn DE, Muchmore DB. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes. Diabetes Obes Metab. 2014 Nov;16(11):1065-9. PubMed PMID: 24840317
• Garg SK, Admane K, Freemantle N, Odawara M, Pan CY, Misra A, Jarek-Martynowa IR, Abbas-Raza S, Mirasol RC, Perfetti R. Patient-led versus Physician-led Titration of Insulin Glargine in Uncontrolled Patients with Type 2 Diabetes: A Randomized Multinational -ATLAS Study. Endocr Pract. 2014 Oct 8;:1-33. [Epub ahead of print] PubMed PMID: 25297660
• Shah VN, Shoskes A, Tawfik B, Garg SK. Closed-loop system in the management of diabetes: past, present, and future. Diabetes Technol Ther. 2014 Aug;16(8):477-90. PubMed PMID: 25072271
• Bode BW, Buse JB, Fisher M, Garg SK, Marre M, Merker L, Renard E, Russell-Jones D, Hansen CT, Rana A, Heller SR: Insulin Degludec Improves Glycemic Control with Lower Nocturnal Hypoglycemia Risk than Insulin Glargine in Basal-Bolus Treatment with Mealtime Insulin Aspart in Type 1 Diabetes (BEGINTM Basal-Bolus Type 1): 2-Year Results of a Randomized Clinical Trial. Diabetic Medicine, 30 (11):1293-1297, 2013.
• Garg SK, Maurer H, Reed K, Selagamsetty R: Diabetes and cancer: Two diseases with obesity as a common risk factor. PMID: 23668396. Diabetes, Obesity and Metabolism, 16:97-110, 2014.
• Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee S, Kaufman FR, for the ASPIRE In-Home Study Group: Threshold-Based Automatic Insulin Pump Feedback for Reduction of Hypoglycemia. NEJM, 369:224-232, 2013.
• Dailey GE, Gao L, Aurand L, Garg SK: Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin. Diabetes, Obesity and Metabolism, 15(12):1085-92, 2013.
• Garg SK, Admane K, Freemantle N, Odawara M, Pan CY, Misra A, Jarek-Martynowa IR, Abbas-Raza S, Mirasol RC, Perfetti R. Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational atlas study. Endocr Pract. 2015 Feb 1;21(2):143-57. PubMed PMID: 25297660
• Weiss R, Garg SK, Bergenstal RM, Klonoff DC, Bode BW, Bailey TS, Thrasher J, Schwartz F, Welsh JB, Kaufman FR. Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin Delivery. J Diabetes Sci Technol. 2015 May 18;9(5):1016-20. PubMed PMID: 25986629
• Bode BW, Garg SK. THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES. Endocr Pract. 2015 Oct 20. [Epub ahead of print] PubMed PMID: 26484403
• Weiss R, Garg SK, Bode BW, Bailey TS, Ahmann AJ, Schultz KA, Welsh JB, Shin JJ. Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study. Diabetes Technol Ther. 2015 Aug;17(8):542-7. PubMed PMID: 26237308
• Sands AT, Zambrowicz BP, Rosenstock J, Lapuerta P, Bode BW, Garg SK, Buse JB, Banks P, Heptulla R, Rendell M, Cefalu WT, Strumph P. Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes. Diabetes Care. 2015 Jul;38(7):1181-8. PubMed PMID: 26049551
• Garg SK, Hirsch IB. Self-monitoring of blood glucose. Diabetes Technol Ther. 2015 Feb;17 Suppl 1:S3-S11. PubMed PMID: 25679428
• Garg SK, Polsky S, Shah VN. New medications for the treatment of diabetes. Diabetes Technol Ther. 2015 Feb;17 Suppl 1:S119-33. PubMed PMID: 25679422
• Basu A, Yu JY, Jenkins AJ, tankervis AJ, Hanssen KF, Henriksen T, Lorentzen B, Garg SK, Menard MK, Hammad SM, Scardo JA, Aston CE, Lyons TJ. Trace elements as predictors of preeclampsia in type 1 diabetic pregnancy. Nutrition Research, 35(5):421-430, 2015
• Ji L, Puhong Z, Wen J, Lu J, Guo X, Jia W, Yang W, Zou D, Zou Z, Pan C, Gao Y, Li X, Zhu D, Li Y, Wu Y, Garg S: Observational registry of basal insulin treatment (ORBIT) in type 2 diabetic patients uncontrolled by oral hypoglycemic agents in China - Study Design and baseline characteristics. Diabetes Technology and Therapeutics, 17 (10):735-744, 2015.
• Schnell O, Barnard K, Bergenstal R, Boss E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P: Clinical utility of SMBG: Recommendations on the use and reporting of SMBG in clinical research. Diabetes Care, 38:1627-1633, 2015
• Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P. Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research. Diabetes Care. 2015 Sep;38(9):1627-33. PubMed PMID: 26294772
• Bode BW, Garg SK. THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES. Endocr Pract. 2016 Feb;22(2):220-30. PubMed PMID: 26484403
• Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Liljenquist DR, Aleppo G, Buse JB, Kruger D, Bhargava A, Goland RS, Edelen RC, Pratley RE, Peters AL, Rodriguez H, Ahmann AJ, Lock JP, Garg SK, Rickels MR, Hirsch IB. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes. Diabetes Care. 2016 Apr;39(4):603-10. PubMed PMID: 26681721
• Garg SK, Hirsch IB. Self-Monitoring of Blood Glucose. Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S3-9. PubMed PMID: 26836428
• Garg SK. The Future of Glucose Monitoring. Diabetes Technol Ther. 2016 Feb;18 Suppl 2:S2iv-22. PubMed PMID: 26784132
• Bhide, Grey JMS, Moser EG, Garg SK: A primary care perspective on the use of continuous glucose monitoring in clinical practice. Diabetes Technology & Therapeutics, 15(7):533-537, 2013
• Klonoff DC, Bergenstal RM, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann A, Welsh JB, Lee SC. ASPIRE In-Home: Rationale, Design, and Methods of a Study to Evaluate the Safety and Efficacy of Automatic Insulin Suspension for Nocturnal Hypoglycemia. Journal of Diabetes Science & Technology, 7(4):1005-1010, 2013
• Shah VN, Moser EG, Blau A, Dhingra M, Garg SK. The future of Basal Insulin. Diabetes Technol Ther, 15(9):727-732, 2013
• Moser EG, Garg SK. Debate – Insulin therapy: a matter of choice? Benefits of the insulin pump are clear, but the pump is not for everyone. Diabetes Voice, 58;34-37, 2013
• Garg SK. DTT: 18 Years and Counting. Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S1. PubMed PMID: 26836421
• Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK: Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen versus Vial-and-Syringe Insulin Delivery in Patients with type 2 Diabetes. PMID: 24266497 Diabetes Technol & Ther, 16(2):76-83, 2014
• Garg SK, Aurand LA, Rimler MS, Dailey GE: Diabetes Duration and the Efficacy and Safety of Insulin Glargine vs. Comparator Treatment in Patients with Type 2 Diabetes Mellitus. PMID: 2013981. Endocrine Practice, 20(2):120-128, 2014
• Bailey TS, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh JB, and Lee SW: Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaneous Glucose Sensor. Diabetes Technol & Ther, 16(5):000-000, 2014
• Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, Kaufman FR. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes. JAMA. 2016 Oct 4;316(13):1407-1408. PubMed PMID: 27629148
• Chase HP and Garg SK: Managing Diabetes in Adults: Type 1 or Type 2, 2013
• Ji L, Zhang P, Zhu D, Li X, Ji J, Lu J, Guo X, Jia W, Weng J, Wu Y, Yang W, Zou D, Zhou Z, Pan C, Gao Y, Garg SK. Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China. Diabetes Obes Metab. 2017 Jan 20. [Epub ahead of print] PubMed PMID: 28105735
• Polsky S, Giordano D, Voelmle M, Garg S: Using technology to advance type 1 diabetes care among women during the reproductive years and in Pregnancy. Post Graduate Medicine 128:418-426, 2016
• Garg S, Dreyer M, Jinnouchi H, Mou J, Qu Y, Hartman ML, Rosilio M, Jacober SJ, Bastyr EJ, on behalf of the IMAGINE 1 Trial Investigators. A Randomized clinical trial comparing basal insulin peglispro and insulin glargine in combination with prandial insulin lisper, in patients with type 1 diabetes: IMAGINE 1 Study. Diabetes Obesity and Metabolism 18;25-33, 2016
• Garg S, Selam JL, Bhargava A, Schloot N, Luo J, Zhang Q, Jacobson JG, Hoogwerf BJ: Similar HbA1c reduction and hypoglycemia with variable vs. fixed time dosing of basal insulin peglispro (BIL) in type 1 diabetes: IMAGINE 7 study. Diabetes Obesity and Metabolism 18:43-49, 2016
• Fonseca VA, Grunsberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, Handelsman Y, Hirsch IB, Orzeck EA, Roberts VL, Tamborlane W: Continuous glucose monitoring: A consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocrine Practice, 22(8):1008-1021, 2016
• Sussman M, Sierra JA, Garg S, Bode B, Friedman M, Gill M, Kaufman F, Vigersky R, Menzin J. Economic impact of hypoglycemia among insulin-treated patients with diabetes. J Med Econ. 2016 Nov;19(11):1099-1106. PubMed PMID: 27292016
• Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu Y, Li X, Ji J, Jia W, Yang W, Zou D, Zhou Z, Gao Y, Garg S, Pan C, Weng J, Paul S on behalf of the ORBIT study group: Comparative effectiveness and safety of three different basal insulins in patients with type 2 diabetes in a real-world setting (ORBIT): A multi center, prospective, registry study. Lancet Diabetes and Endocrinology, 4:S34, 2016
• Ji L, Zhang P, Zhu D, Lu J, Guo X, Wu Y, Li X, Ji J, Jia W, Yang W, Zou D, Zhou Z, Gao Y, Garg S, Pan C, Weng J, Paul S on behalf of the ORBIT study group: Comparative effectiveness and safety of three different basal insulins in patients with type 2 diabetes in a real-world setting (ORBIT): A multi center, prospective, registry study. Lancet Diabetes and Endocrinology, 4:S34, 2016
• Garg SK. DTT: 19 Years and Counting …. Diabetes Technol Ther. 2017 Feb;19(S1):S1. PubMed PMID: 28192028
• Garg SK, Hirsch IB. Self-Monitoring of Blood Glucose. Diabetes Technol Ther. 2017 Feb;19(S1):S3-S10. PubMed PMID: 28192021
• Garg SK, Giordano D, Gallo T, Shah VN. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2017 Feb;19(S1):S128-S140. PubMed PMID: 28192022
• Buckingham BA, Bailey TS, Christiansen M, Garg S, Weinzimer S, Bode B, Anderson SM, Brazg R, Ly TT, Kaufman FR. Evaluation of a Predictive Low-Glucose Management System In-Clinic. Diabetes Technol Ther. 2017 May;19(5):288-292. PubMed PMID: 28221823
• Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 Mar;19(3):155-163. PubMed PMID: 28134564
• Christiansen MP, Garg SK, Brazg R, Bode BW, Bailey TS, Slover RH, Sullivan A, Huang S, Shin J, Lee SW, Kaufman FR. Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor. Diabetes Technol Ther. 2017 Aug;19(8):446-456. PubMed PMID: 28700272
• Garg SK, Akturk HK. Flash Glucose Monitoring: The Future Is Here. Diabetes Technol Ther. 2017 May;19(S2):S1-S3. PubMed PMID: 28541133
• Garg SK, Akturk HK. The Future of Continuous Glucose Monitoring. Diabetes Technol Ther. 2017 Jun;19(S3):S1-S2. PubMed PMID: 28585872
• Schnell O, Barnard K, Bergenstal R, Bosi E, Garg S, Guerci B, Haak T, Hirsch IB, Ji L, Joshi SR, Kamp M, Laffel L, Mathieu C, Polonsky WH, Snoek F, Home P. Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting. Diabetes Technol Ther. 2017 Jul;19(7):391-399. PubMed PMID: 28530490
• Garg SK, Shah VN, Akturk HK, Beatson C, Snell-Bergeon JK. Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar(®) in Type 1 Diabetes Management. Diabetes Ther. 2017 Aug;8(4):811-819. PubMed PMID: 28555339
• Garg SK, Wernicke-Panten K, Rojeski M, Pierre S, Kirchhein Y, Jedynasty K. Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 1 Diabetes Also Using Insulin Glargine-SORELLA 1 Study. Diabetes Technol Ther. 2017 Sep;19(9):516-526. PubMed PMID: 28722480
• Kelly CB, Hookham MB, Yu JY, Lockhart SM, Du M, Jenkins AJ, Nankervis A, Hanssen KF, Henriksen T, Garg SK, Hammad SM, Scardo JA, Aston CE, Patterson CC, Lyons TJ. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes. Diabetologia. 2017 Dec;60(12):2514-2524. PubMed PMID: 28875223
• Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D, Lapuerta P, Simó R, Danne T, McGuire DK, Kushner JA, Peters A, Strumph P. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes. N Engl J Med. 2017 Dec 14;377(24):2337-2348. PubMed PMID: 28899222
• Garg SK, Polsky S. Continuous glucose monitoring in pregnant women with type 1 diabetes. Lancet. 2017 Nov 25;390(10110):2329-2331. PubMed PMID: 28923466
• Garg SK. Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes. Diabetes Technol Ther. 2017 Oct;19(10):549-551. PubMed PMID: 28891680
• Thrasher J, Surks H, Nowotny I, Pierre S, Rotthaeuser B, Wernicke-Panten K, Garg S. Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump. J Diabetes Sci Technol. 2018 May;12(3):680-686. PubMed PMID: 29359575
• Garg SK. Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes. Diabetes Technol Ther. 2017 Oct;19(10):549-551. PubMed PMID: 28891680
• Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care. 2017 Dec;40(12):1631-1640. PubMed PMID: 29162583
• Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Menard MK, Aston CE, Lyons TJ. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care. 2018 Jan;41(1):120-127. PubMed PMID: 29122892
• Cordero TL, Garg SK, Brazg R, Bailey TS, Shin J, Lee SW, Kaufman FR. The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed(™) 670G Hybrid Closed-Loop System. Diabetes Technol Ther. 2017 Dec;19(12):749-752. PubMed PMID: 29148821
• Home P, Derwahl KM, Ziemen M, Wernicke-Panten K, Pierre S, Kirchhein Y, Garg SK. Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes. Diabetes Technol Ther. 2018 Feb;20(2):160-170. PubMed PMID: 29355435
• Garg SK. DTT: 20 Years and Counting …. Diabetes Technol Ther. 2018 Feb;20(S1):S1. PubMed PMID: 29437469
• Garg SK, Rewers AH, Akturk HK. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2018 Feb;20(S1):S139-S153. PubMed PMID: 29437472
• Garg SK, Hirsch IB. Self-Monitoring of Blood Glucose. Diabetes Technol Ther. 2018 Feb;20(S1):S3-S12. PubMed PMID: 29437471
• Garg SK, Strumph P. Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes. N Engl J Med. 2018 Mar 8;378(10):967-968. PubMed PMID: 29514037
• Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. J Clin Invest. 2018 May 1;128(5):1888-1902. PubMed PMID: 29438107
• Bjornstad P, Maahs DM, Roncal CA, Snell-Bergeon JK, Shah VN, Milagres T, Ellis SL, Hatch M, Chung LT, Rewers MJ, Garg S, Cherney DZ, Pyle L, Nadeau KJ, Johnson RJ. Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes. Diabetes Obes Metab. 2018 Jul;20(7):1776-1780. PubMed PMID: 29498467
• Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Menard MK, Aston CE, Lyons TJ. Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127. Diabetes Care. 2018 Jun;41(6):e102-e103. PubMed PMID: 29784706
• Buse JB, Garg SK, Rosenstock J, Bailey TS, Banks P, Bode BW, Danne T, Kushner JA, Lane WS, Lapuerta P, McGuire DK, Peters AL, Reed J, Sawhney S, Strumph P. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study. Diabetes Care. 2018 Sep;41(9):1970-1980. PubMed PMID: 29937430
• Garg SK, Rewers AH, Akturk HK. Ever-Increasing Insulin-Requiring Patients Globally. Diabetes Technol Ther. 2018 Jun;20(S2):S21-S24. PubMed PMID: 29873518
• Akturk HK, Rewers A, Joseph H, Schneider N, Garg SK. Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes. Diabetes Technol Ther. 2018 Jun;20(S2):S224-S232. PubMed PMID: 29916737
• Garg SK, Akturk HK. A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices. Diabetes Technol Ther. 2018 Jun;20(6):391-394. PubMed PMID: 29901411
• Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator. Diabetes Technol Ther. 2018 Jun;20(6):428-433. PubMed PMID: 29923775
• Wadwa RP, Laffel LM, Shah VN, Garg SK. Accuracy of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System During 10 Days of Use in Youth and Adults with Diabetes. Diabetes Technol Ther. 2018 Jun;20(6):395-402. PubMed PMID: 29901421
• Akturk HK, Rewers A, Garg SK. SGLT inhibition: a possible adjunctive treatment for type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2018 Aug;25(4):246-250. PubMed PMID: 29794497
• Garg SK, Peters AL, Buse JB, Danne T. Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol. Diabetes Technol Ther. 2018 Sep;20(9):571-575. PubMed PMID: 30129772
• Akturk HK, Snell-Bergeon JK, Rewers A, Klaff LJ, Bode BW, Peters AL, Bailey TS, Garg SK. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. Diabetes Technol Ther. 2018 Oct;20(10):639-647. PubMed PMID: 30207748
• Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, Maahs DM, Tamborlane WV, Bergenstal R, Smith E, Olson BA, Garg SK. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019 Feb;21(2):66-72. PubMed PMID: 30657336
• Garg SK, Hirsch IB. Self-Monitoring of Blood Glucose. Diabetes Technol Ther. 2019 Feb;21(S1):S4-S12. PubMed PMID: 30785324
• Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, Maahs DM, Tamborlane WV, Bergenstal R, Smith E, Olson BA, Garg SK. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019 Feb;21(2):66-72. PubMed PMID: 30657336
• Garg SK, Giordano D. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2019 Feb;21(S1):S160-S171. PubMed PMID: 30785325
• DeSouza C, Cariou B, Garg S, Lausvig N, Navarria A, Fonseca V. Efficacy and safety of semaglutide for type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials. J Clin Endocrinol Metab. 2019 Nov 26. [Epub ahead of print] PubMed PMID: 31769496
• Garg SK, Parkin CG. The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care. Diabetes Technol Ther. 2019 Jun;21(S2):S21-S23. PubMed PMID: 31169425
• Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4743-4755. PubMed PMID: 31219590
• Fonseca VA, Capehorn MS, Garg SK, Jódar Gimeno E, Hansen OH, Holst AG, Nayak G, Seufert J. Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide. J Clin Endocrinol Metab. 2019 Apr 2. [Epub ahead of print] PubMed PMID: 30938762
• Danne T, Pettus J, Giaccari A, Cariou B, Rodbard H, Weinzimer SA, Bonnemaire M, Sawhney S, Stewart J, Wang S, Castro RC, Garg SK. Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2019 Sep;21(9):471-477. PubMed PMID: 31335194
• Leahy JJL, Aleppo G, Fonseca VA, Garg SK, Hirsch IB, McCall AL, McGill JB, Polonsky WH. Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations. J Endocr Soc. 2019 Oct 1;3(10):1942-1957. PubMed PMID: 31608313
• Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019 Aug;42(8):1593-1603. PubMed PMID: 31177185
• Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4743-4755. PubMed PMID: 31219590
• Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4743-4755. PubMed PMID: 31219590
• Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4743-4755. PubMed PMID: 31219590
• Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4743-4755. PubMed PMID: 31219590
• Kelly CB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Basu A, Hammad SM, Aston CE, Lyons TJ. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4743-4755. PubMed PMID: 31219590
• Garg SK, Shah V. Closed-loop insulin delivery systems for patients with diabetes. The Lancet Digital Health, 1(1):Pe2-Pe3, 2019, :https://doi.org/10.1016/S2589-7500(19)3007-X
• Garg SK, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Mukherjee B, Shah VN. Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combination with Insulin Glargine: A Randomized Open-Label Trial (GEMELLI 1). Diabetes Technol Ther. 2020 Feb;22(2):85-95. PubMed PMID: 31804851
• Thrasher J, Polsky S, Hovsepian L, Nowotny I, Pierre S, Bois De Fer B, Bhargava A, Mukherjee B, Garg SK. Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial. Diabetes Technol Ther. 2020 Sep;22(9):666-673. PubMed PMID: 31833801
• Garg K, Brackett S, Hirsch IB, Garg SK. NAFLD/NASH and Diabetes. Diabetes Technol Ther. 2020 Feb;22(S1):S174-S186. PubMed PMID: 32069155
• Garg SK, Brackett S, Reinicke T, Hirsch IB. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2020 Feb;22(S1):S149-S173. PubMed PMID: 32069157
• Garg SK. Reflections on Diabetes Care at the End of the Second Decade of the 21st Century. Diabetes Technol Ther. 2020 Feb;22(2):63-65. PubMed PMID: 31916843
• Garg SK. DTT : 22 Years and Counting…. Diabetes Technol Ther. 2020 Feb;22(S1):S1. PubMed PMID: 32069153
• DeSouza C, Cariou B, Garg S, Lausvig N, Navarria A, Fonseca V. Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials. J Clin Endocrinol Metab. 2020 Feb 1;105(2). PubMed PMID: 31769496
• Garg SK, Wernicke-Panten K, Wardecki M, Kramer D, Delalande F, Franek E, Sadeharju K, Monchamp T, Miossec P, Mukherjee B, Shah VN. Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 Trial. Diabetes Technol Ther. 2020 Jul;22(7):516-526. PubMed PMID: 32068436
• Garg SK, Rodbard D, Hirsch IB, Forlenza GP. Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities. Diabetes Technol Ther. 2020 Jun;22(6):431-439. PubMed PMID: 32302499
• Peters AL, Garg SK. The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. Diabetes Technol Ther. 2020 Jun;22(6):449-453. PubMed PMID: 32383989
• Kelly CB, Wagner CL, Shary JR, Leyva MJ, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Aston CE, Lyons TJ. Vitamin D Metabolites and Binding Protein Predict Preeclampsia in Women with Type 1 Diabetes. Nutrients. 2020 Jul 10;12(7). PubMed PMID: 32664257
• Bode B, Garg S, Norwood P, Morales C, Hardy T, Liu R, Ignaut D. Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study. Diabetes Technol Ther. 2020 Jul 30. [Epub ahead of print] PubMed PMID: 32640842
• Phillip M, Bergenstal RM, Close KL, Danne T, Garg SK, Heinemann L, Hirsch IB, Kovatchev BP, Laffel LM, Mohan V, Parkin CG, Battelino T. The Digital/Virtual Diabetes Clinic - the Future is Now. Recommendations from an International Panel on Diabetes Digital Technologies Introduction. Diabetes Technol Ther. 2020 Sep 9. [Epub ahead of print] PubMed PMID: 32905711
• Akturk HK, Giordano D, Champakanath A, Brackett S, Garg S, Snell-Bergeon J. Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes. Diabetes Obes Metab. 2020 Apr;22(4):583-589. PubMed PMID: 31789447
• Bode BW, Garg SK, Norwood P, Morales C, Hardy T, Liu R, Ignaut D. Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study. Diabetes Technol Ther. 2021 Jan;23(1):41-50. PubMed PMID: 32640842
• Rodbard D, Garg SK. Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose Monitoring. Diabetes Technol Ther. 2021 Mar;23(3):221-226. PubMed PMID: 33480828
• van der Linden J, Welsh JB, Hirsch IB, Garg SK. Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range. Diabetes Technol Ther. 2021 Mar;23(S1):S1-S7. PubMed PMID: 33470892
• Shah VN, Garg SK. Standardized Hybrid Closed-Loop System Reporting. Diabetes Technol Ther. 2021 May;23(5):323-331. PubMed PMID: 33252264
• Phillip M, Bergenstal RM, Close KL, Danne T, Garg SK, Heinemann L, Hirsch IB, Kovatchev BP, Laffel LM, Mohan V, Parkin CG, Battelino T. The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction. Diabetes Technol Ther. 2021 Feb;23(2):146-154. PubMed PMID: 32905711
• Rodbard HW, Giaccari A, Cariou B, Garg S, Davies MJ, Seth K, Sawhney S. Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTandem2. Diab Vasc Dis Res. 2021 Jan-Feb;18(1):1479164121995928. PubMed PMID: 33611925
• Garg SK. DTT: 23 Years and Counting. Diabetes Technol Ther. 2021 Jun;23(S2):S1. PubMed PMID: 34061642
• Garg SK, Reinicke T. COVID-19 Pandemic and Virtual Clinics for Diabetes Care. Diabetes Technol Ther. 2021 Jun;23(S2):S3-S15. PubMed PMID: 34061640
• Garg SK, Hirsch IB. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2021 Jun;23(S2):S185-S197. PubMed PMID: 34061636
• Garg K, Reinicke T, Garg SK. NAFLD and NASH and Diabetes. Diabetes Technol Ther. 2021 Jun;23(S2):S198-S205. PubMed PMID: 34061630
• Garg SK, Liljenquist D, Bode B, Christiansen MP, Bailey TS, Brazg RL, Denham DS, Chang AR, Akturk HK, Dehennis A, Tweden KS, Kaufman FR. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technol Ther. 2021 Sep 9. [Epub ahead of print] PubMed PMID: 34515521
• Garg SK, Liljenquist D, Bode B, Christiansen MP, Bailey TS, Brazg RL, Denham DS, Chang AR, Akturk HK, Dehennis A, Tweden KS, Kaufman FR. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technol Ther. 2021 Sep 9. [Epub ahead of print] PubMed PMID: 34515521
• Garg SK. Emerging Landscape of Continuous Glucose Monitoring. Diabetes Technol Ther. 2021 Sep;23(S3):S1-S4. PubMed PMID: 34546083
• Akturk HK, Snell-Bergeon J, Pyle L, Fivekiller E, Garg S, Cobry E. Accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. J Diabetes Complications. 2021 Aug 27;:108030. [Epub ahead of print] PubMed PMID: 34481712
• Sherr, CA, Schulman, D, Garg S et. al.: safety and Glycemic outcomes during the Minimed advanced hybrid-closed-loop system pivotal trial in adolescents and adults with type 1 diabetes: Diabetes Technology and Therapeutics 2021; 23
• Carlson AL, Sherr JL, Shulman DI, Garg SK, Pop-Busui R, Bode BW, Lilenquist DR, Brazg RL, Kaiserman KB, Kipnes MS, Thrasher JR, Reed JHC, Slover RH, Philis-Tsimikas A, Christiansen M, Grosman B, Roy A, Vella M, Jonkers RAM, Chen X, Shin J, Cordero TL, Lee SW, Rhinehart AS, Vigersky RA. Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 Mar;24(3):178-189. PubMed PMID: 34694909
• Garg SK, Rodriguez E, Shah VN, Hirsch IB. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2022 Mar;24(S1):S190-S208. PubMed PMID: 35475687
• Garg SK, Rodriguez E. COVID-19 Pandemic and Diabetes Care. Diabetes Technol Ther. 2022 Mar;24(S1):S2-S20. PubMed PMID: 35475690
• Garabedian C, Plurien A, Benoit L, Kyheng M, Thuillier C, Sanchez M, Turcsak A, Rozenberg P, Berveiller P. Is sonographic measurement of head-perineum distance useful to predict obstetrical anal sphincter injury in case of vacuum delivery?. Int J Gynaecol Obstet. 2022 Mar 8. [Epub ahead of print] PubMed PMID: 35262188
• Garg SK, Kipnes M, Castorino K, Bailey TS, Akturk HK, Welsh JB, Christiansen MP, Balo AK, Brown SA, Reid JL, Beck SE. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther. 2022 Jun;24(6):373-380. PubMed PMID: 35157505
• Weinstock RS, Bode BW, Garg SK, Klonoff DC, El Sanadi C, Geho WB, Muchmore DB, Penn MS. Reduced hypoglycaemia using liver-targeted insulin in individuals with type 1 diabetes. Diabetes Obes Metab. 2022 Sep;24(9):1762-1769. PubMed PMID: 35546449
• Pettus J, Boeder SC, Christiansen MP, Denham DS, Bailey TS, Akturk HK, Klaff LJ, Rosenstock J, Cheng MHM, Bode BW, Bautista ED, Xu R, Yan H, Thai D, Garg SK, Klein S. Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nat Med. 2022 Oct 3. [Epub ahead of print] PubMed PMID: 36192552
• Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O'Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice. Endocr Rev. 2022 Sep 6. [Epub ahead of print] PubMed PMID: 36066457
• 337. Garg SK, Rodriguez E, Almurashi AM. Continuous Glucose Monitors/Hybrid Closed Loop Systems. Medscape, 2022. https://emedicine.medscape.com/article/2500145-overview. Sep 06, 2022
• Almurashi AM, Rodriguez E, Garg SK.Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases. Journal of Indian Institute of Sciences
• Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O'Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocr Rev. 2023 Mar 4;44(2):254-280. PubMed PMID: 36066457
• Garg SK, Almurashi AM, Rodriguez E. Virtual Clinics for Diabetes Care. Diabetes Technol Ther. 2023 Feb;25(S1):S2-S14. PubMed PMID: 36802190
• Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. PubMed PMID: 36493795
• Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, Pop-Busui R, Philis-Tsimikas A, Kipnes M, Liljenquist DR, Brazg RL, Kudva YC, Buckingham BA, McGill JB, Carlson AL, Criego AB, Christiansen MP, Kaiserman KB, Griffin KJ, Forlenza GP, Bode BW, Slover RH, Keiter A, Ling C, Marinos B, Cordero TL, Shin J, Lee SW, Rhinehart AS, Vigersky RA. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial. Diabetes Technol Ther. 2023 Jan;25(1):1-12. PubMed PMID: 36472543
• Garg SK. Past, Present, and Future of Continuous Glucose Monitors. Diabetes Technol Ther. 2023 Jun;25(S3):S1-S4. PubMed PMID: 36749142
• Garg SK, Almurashi AM, Rodriguez E. Virtual Clinics for Diabetes Care. Diabetes Technol Ther. 2023 Feb;25(S1):S2-S14. PubMed PMID: 36802190
• Garg SK, Rodriguez E, Hirsch IB. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2023 Feb;25(S1):S207-S216. PubMed PMID: 36802185
• Bailey R, Calhoun P, Garg SK. Weight Gain and Glycemic Control in Adults with Type 1 Diabetes in the T1D Exchange Registry. Diabetes Technol Ther. 2024 Mar;26(3):156-160. PubMed PMID: 38444314
• Garg SK, Rewers AH, Kaur G. Virtual Clinics for Diabetes Care. Diabetes Technol Ther. 2024 Mar;26(S1):S2-S13. PubMed PMID: 38441449
• Garg SK, Kaur G, Rewers AH, Hirsch IB. New Medications for the Treatment of Diabetes. Diabetes Technol Ther. 2024 Mar;26(S1):S219-S230. PubMed PMID: 38441456
• Sridhar VS, Heerspink HJL, Davies MJ, Banks P, Girard M, Garg SK, Cherney DZI. The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3. Diabetes Care. 2023 Jul 1;46(7):e133-e135. PubMed PMID: 37172207
• Garg SK, Kaur G, Haider Z, Rodriquez E, Beatson C, Snell-Bergeon J. Efficacy of Semaglutide in Overweight and Obese Patients with Type 1 Diabetes. Diabetes Technol Ther. 2024 Mar;26(3):184-189. PubMed PMID: 38444317
• Kelly CB, Karanchi H, Yu JY, Leyva MJ, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Aston CE, Beisswenger PJ, Lyons TJ. Plasma AGE and Oxidation Products, Renal Function, and Preeclampsia in Pregnant Women with Type 1 Diabetes: A Prospective Observational Study. J Diabetes Res. 2023;2023:8537693. PubMed PMID: 37601831
• Garg SK, McVean JJ. Development and Future of Automated Insulin Delivery (AID) Systems. Diabetes Technol Ther. 2024 Mar;26(S3):1-6. PubMed PMID: 38377322
• Garg SK, Akturk HK, Kaur G, Beatson C, Snell-Bergeon J. Efficacy and Safety of Tirzepatide in Overweight and Obese Adult Patients with Type 1 Diabetes. Diabetes Technol Ther. 2024 Jun;26(6):367-374. PubMed PMID: 38512447
• Garg SK, Polsky S. Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes. N Engl J Med. 2023 Oct 5. [Epub ahead of print] PubMed PMID: 37796238
• Garg SK, Snell-Bergeon J, Kaur G, Beatson C. Challenges of GLP Analog Use for People with Type 1 Diabetes: Issues with Prior Approvals and Tips for Safer Use. Diabetes Technol Ther. 2024 Jun;26(6):363-366. PubMed PMID: 38517221
• Boeder S, Davies MJ, McGill JB, Pratley R, Girard M, Banks P, Pettus J, Garg S. Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin. Diabetes Technol Ther. 2024 Sep;26(9):618-625. PubMed PMID: 38441906
• Garg SK, Hirsch IB, Repetto E, Snell-Bergeon J, Ulmer B, Perkins C, Bergenstal RM. Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis. Diabetes Obes Metab. 2024 Nov;26(11):5202-5210. PubMed PMID: 39263872
• Garg SK, Almurashi AM, Rodriguez E. Virtual Clinics for Diabetes Care. Diabetes Technol Ther. 2023 Feb;25(S1):S2-S14. PubMed PMID: 36802190
• Almurashi AM, Rodriguez E, Garg SK. Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases. J Indian Inst Sci. 2023 Mar 28;:1-26. [Epub ahead of print] PubMed PMID: 37362851

Professional Memberships

• ADA, Member
• EASD, Member
• Scientific Chair Clinical Therapeutic area ADA, 2007-2009
• Editor-in-Chief Diabetes Technology and Therapeutics Journal, 2007
• ESI and RSSDI, 1982

Practice Locations

Barbara Davis Center for Diabetes Adult Clinic - CU Anschutz Medical Campus
1775 Aurora Ct
Suite A140
Aurora, CO 80045
303-724-6755

Hospital Affiliation

• University of Colorado Hospital

Center Affiliations

• Barbara Davis Center for Childhood Diabetes

Specialty Information

Specialties

• Endocrinology, Diabetes and Metabolism, Board Certification (1982)
• Internal Medicine, Board Certification (1979)

Conditions & Treatments

• Endocrine System (Hormones) - Adult Type 1 Diabetes
• Endocrine System (Hormones) - Thyroid Disease
• Child and Teen Health - Juvenile Diabetes
• Child and Teen Health
• Endocrine System (Hormones)